[Helpful instrumental examinations in idiopathic Parkinson's disease]
Autor: | Walter, U., Zach, H., Liepelt-Scarfone, I., Maetzler, W. |
---|---|
Jazyk: | němčina |
Rok vydání: | 2017 |
Předmět: |
Evidence-Based Medicine
methods [Positron-Emission Tomography] Brain Parkinson Disease bacterial infections and mycoses Disorders of movement Donders Center for Medical Neuroscience [Radboudumc 3] Echoencephalography Magnetic Resonance Imaging methods [Echoencephalography] Molecular Imaging Diagnosis Differential methods [Magnetic Resonance Imaging] methods [Tomography X-Ray Computed] methods [Molecular Imaging] Positron-Emission Tomography diagnostic imaging [Parkinson Disease] Humans ddc:610 Tomography X-Ray Computed diagnostic imaging [Brain] |
Zdroj: | Nervenarzt, 88, 4, pp. 365-372 Nervenarzt, 88, 365-372 Der Nervenarzt 88(4), 365-372 (2017). doi:10.1007/s00115-017-0289-z |
ISSN: | 1433-0407 0028-2804 |
DOI: | 10.1007/s00115-017-0289-z |
Popis: | Item does not contain fulltext BACKGROUND: The clinical diagnosis of idiopathic Parkinson's disease (iPD) can be challenging. In these cases, additional diagnostic methods are available that can help to improve diagnostic accuracy. OBJECTIVES, MATERIAL AND METHODS: This article provides an overview of currently available and promising novel ancillary methods for the early and differential diagnosis of iPD. RESULTS: Imaging tools, such as 1.5 Tesla magnetic resonance imaging (MRI) and computed tomography (CT) are mainly used for the differentiation between iPD and symptomatic parkinsonian syndromes (PS). High-resolution diffusion tensor imaging and iron and neuromelanin-sensitive high-field MRI sequences can become important in the future, particularly for earlier diagnosis. Transcranial Bmode sonography of the substantia nigra and basal ganglia is established for early and differential diagnostics, especially in the combination of diagnostic markers but necessitates an adequately trained investigator and the use of validated digital image analysis instruments. DATScan can discriminate iPD from essential tremor, medication-induced parkinsonism and psychogenic movement disorder but not iPD from atypical PS. For the latter differential diagnosis, fluorodeoxyglucose positron emission tomography and myocardial metaiodobenzylguanidine scintigraphy can be helpful. Olfactory testing should preferably be used in combination with other diagnostic tests. Genetic, biochemical and histopathological tests are currently not recommended for routine use. Novel sensor-based techniques have a high potential to support clinical diagnosis of iPD but have not yet reached a developmental stage that is sufficient for clinical use. Novel sensor-based techniques have high potential to support clinical diagnosis of iPD, but have not yet reached a development stage that is sufficient for clinical use. CONCLUSION: Ancillary diagnostic methods can support the early and differential diagnosis of iPD. |
Databáze: | OpenAIRE |
Externí odkaz: |